INTRODUCTION Helicobacter (H.) hepaticus infection causes chronic active hepatitis and induces hepatocellular tumours in A/JCr mice, but evidence of this in humans is scarce. This study aimed to demonstrate the correlation between H. hepaticus and human primary hepatocellular carcinoma (HCC).
I NTRO D U C TIO N
Primary hepatocellular carcinoma (HCC), the most common malignant tumour of the digestive tract, features long disease duration and poor prognosis, with liver cirrhosis complicating almost all of its malignancies.
(1) Studies have indicated that chronic liver damage, caused by various factors, activates oncogenes and inactivates tumour suppressor genes through the signal transduction system and a variety of complicated mechanisms, ultimately resulting in the development of HCC. (2) However, the pathogenesis of primary HCC is still not fully understood. Chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infections are important pathogenic factors of liver cirrhosis and HCC, (1) as are other non-viral factors such as alcohol-related injury, haemoglobin intoxication, primary biliary cirrhosis and aflatoxin use.
Epidemiological studies have shown that a majority of liver cirrhosis and HCC cases are associated with chronic viral infections. (3) In contrast, case analyses have revealed no necessary correlation between these diseases and viral infections. (4) Multicentre follow-up studies have demonstrated that liver injury caused by hepatitis virus infection alone is a long-term chronic process that exhibits no correlation with the occurrence of liver cirrhosis. 
Since its initial identification, H. pylori infection has not
only been considered a major pathogenic factor for chronic gastritis, peptic ulcer, gastric cancer and mucosa-associated lymphoid tissue lymphoma of the stomach, (8, 9) it has also been found to be closely related to chronic liver disease. (10) First discovered in 1992, infection with H. hepaticus was shown to cause chronic active hepatitis that ultimately induced the development of hepatocellular tumours in A/JCr mice. (11) Therefore, H. hepaticus infection is deemed to be an important pathogenic factor for liver cirrhosis and HCC, in addition to hepatitis virus infection. While the DNA of Helicobacter spp. has been detected in the liver and bile
Helicobacter hepaticus infection in primary hepatocellular carcinoma tissue duct tissues of patients with chronic liver diseases, the specific Helicobacter spp. in question have not been identified. (12) (13) (14) This is mainly attributed to the extreme difficulty encountered in the separation of Helicobacter from liver tissues, as well as in the subsequent culture process. The current commonly used molecular biology technique for identifying Helicobacter consists of detecting Helicobacter-specific 16S rRNA genes using polymerase chain reaction (PCR). (15) Although an association between H. hepaticus infection and human pancreatic and biliary diseases has been demonstrated using serological analysis with specific antibodies, (16) 
M e Th O Ds
A total of 50 patients with primary HCC, diagnosed via surgical resection and liver puncture biopsy at the China-
Japan Union Hospital of Jilin University and Jilin Provincial
Cancer Hospital, Changchun, China, between January 2008 and October 2011, were enrolled in the present study. The patients in the study group, who had a mean age of 56.9 ± 9.5
(range 36-79) years and consisted of 37 men and 13 women, were assigned to one of two subgroups according to the occurrence of complicating viral hepatitis. Of the 50 patients, 39 were assigned to the complicating viral hepatitis subgroup, while 11 patients were assigned to the non-complicating viral hepatitis subgroup. All patients were diagnosed with primary HCC using pathological or histological examinations. (17, 18) DNA samples were extracted from the liver tissues using the 3S-column extraction method, and all reagents used were supplied by Sangon Biotech Co Ltd. PCR amplification was performed with a total volume of 50 μL, Table I .
The H. hepaticus-specific 16S rRNA-positive product underwent PCR amplification. After which, the resulting product was electrophoresed on gels, purified and sequenced by Takara Biotechnology Co Ltd, Dalian, China.
The sequencing results were aligned with the known sequence of H. hepaticus-specific 16S rRNA from the 
ResUlTs
There were no significant differences between the study group and the two control groups in terms of age, gender or severity of liver damage (Table II) . However, a significantly higher proportion of patients with abnormal serum aminotransferase levels was observed in the primary HCC group as compared to the benign liver tumour and normal liver tissue groups. Among the patients in the study group, no significant differences in terms of age, gender, severity of liver damage and serum aminotransferase levels were detected between patients with either HBV or HCV infection and those without (Table III) .
Anti-H. pylori and anti-H. hepaticus IgG antibodies were detected in the sera of patients in all three groups (primary HCC, benign liver tumour and normal liver tissue groups).
However, significantly higher detection rates (p < 0.001) for anti-H. were amplified using PCR assay. Agarose gel electrophoresis of the PCR amplification products of patients with primary HCC are shown in Fig. 1 Table V) . The rate of positive detection of 
DIsCUssION
H. hepaticus infection has been shown to cause chronic active hepatitis and induce HCC in A/JCr mice. (11) This finding adds to the current understanding of the pathogenic factors of HCC. In addition, mouse strain, genetic background, (19) gender, and age at the time of H. hepaticus infection (2-12 weeks) was also shown to determine the final outcome of liver disease. (20) 
To increase assay specificity in the present study, the anti- (29) In one study that used ELISA, using the specific monoclonal antibody HR II-51, the H. hepaticus antigen was detected in the sera of patients with common liver diseases, hepatic cirrhosis and hepatitis complicated by HBV or HCV infection. (31) The highest H. hepaticus antigen level was found in the sera of patients with hepatic cirrhosis, followed by that in the sera of patients with hepatitis complicated by HBV or HCV infection. These groups had H. hepaticus antigen levels that were significantly higher than those in patients with common liver diseases. H. hepaticus infection has been suggested to accelerate the progression of HBV and HCV infection. (31) The present study showed that the rate of positive detection of anti-H. 
